A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas
Clinical trial NCT04306224 · COMPLETED
Trial details
- NCT number
- NCT04306224
- Sponsor
- ImmuneOncia Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2022-10-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.